Akathisia - A brief review

Scottish Medical Journal

Volumn 46, Issue 5, 2001, Pages 133-134

  Nelson, D E ^a  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMISULPRIDE; AMPHETAMINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLONIDINE; CYPROHEPTADINE; DIAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; METOCLOPRAMIDE; MIANSERIN; NEUROLEPTIC AGENT; NICOTINE; PIRACETAM; PROPRANOLOL; RISPERIDONE;

AKATHISIA; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HUMAN; INCIDENCE; NOTE; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; RATING SCALE; SYMPTOM; TREATMENT PLANNING;

EID: 0035213431     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1177/003693300104600502     Document Type: Note

References (23)

1. Akathisia: Prevalence and associated dysphoria in an in-patient population with chronic schizophrenia
2. Drug induced akathisia revisited
3. Akathisia: A comprehensive review and treatment summary
4. Drug induced akathisia and suicidal tendencies in psychotic patients
5. Suicide attempts associated with akathisia
6. A rating scale for drug induced akathisia
7. The epidemiology of drug induced akathisia: Part i. Acute akathisia
8. Clinical characteristics and predisposing factors in acute drug induced akathisia
9. Managing antipsychotic induced acute and chronic akathisia
10. The epidemiology of drug induced akathisia: Part II. Chronic, tardive and withdrawal akathisia
11. Positron emission tomographic analysis of central D 1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects
12. Prevalence and severity of akathisia in patients on clozapine
13. Restless legs syndrome
14. Akathisia variants and tardive dyskinesia
15. The risks and benefits of clozapine verses chlorpromazine
16. Clozapine and akathisia
17. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapme, risperidone, and conventional antipsychotics
18. Cyprobeptadine treatment in neuroleptic induced akathisia
19. Treatment of neuroleptic induced akathisia with the SHT2 antagonist mianserin
20. Treatment of neuroleptic: Induced akathisia with nicotine patches